HB Wealth Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$984K Buy
1,858
+69
+4% +$31.8K 0.01% 749
2026
Q1
$859K Buy
1,789
+235
+15% +$120K 0.01% 728
2025
Q4
$873K Buy
1,554
+330
+27% +$187K 0.01% 680
2025
Q3
$629K Buy
1,224
+456
+59% +$199K ﹤0.01% 760
2025
Q2
$241K Sell
768
-71
-8% -$21.3K ﹤0.01% 1031
2025
Q1
$256K Buy
+839
New +$282K ﹤0.01% 1033

Other funds holding MEDP

HB Wealth Management's MEDP Position: Q2 2026 in Review

HB Wealth Management increased its Medpace (MEDP) stake by 3.9% in Q2 2026, buying an estimated $31.8K and bringing the position to 1,858 shares worth $984K. The position accounts for 0.01% of the portfolio, ranked #749.

HB Wealth Management first reported a position in MEDP in Q1 2025 and has held it in 6 quarters since. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • HB Wealth Management held 1,858 shares of Medpace worth $984K as of Q2 2026.
  • HB Wealth Management bought 69 Medpace shares in Q2 2026, an estimated $31.8K.
  • Medpace made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #749 holding.
  • HB Wealth Management first reported a position in Medpace in Q1 2025 and has held it in 6 quarters since.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.